Clinical prediction model of Mycoplasma pneumoniae pneumonia combined with influenza virus infection in pediatric patients in Gansu, China

中国甘肃省儿童肺炎支原体肺炎合并流感病毒感染的临床预测模型

阅读:2

Abstract

BACKGROUND: The incidence of respiratory infections in children has been increasing in recent years, and co-infections can lead to additional complications. This study aimed to investigate predictors of Mycoplasma pneumoniae pneumonia (MPP) co-infected with influenza virus through a retrospective analysis of clinical data in pediatric patients. METHODS: We retrospectively reviewed the medical records of 195 children diagnosed with MPP at the Pediatric Internal Medicine Department of Gansu Provincial Hospital between November 2023 and November 2024. Patients were categorized into two groups: single-infection (n = 128, MPP alone) and mixed-infection (n = 67, MPP co-infected with influenza). Predictors of mixed infection were identified using a multivariate logistic regression-based prediction model. The model's discrimination, accuracy, clinical utility, and generalizability were evaluated using receiver operating characteristic (ROC) curve analysis and decision curve analysis (DCA). RESULTS: Multivariate analysis showed that influenza season, fibrinogen (Fib) level, fever duration, and C-reactive protein (CRP) were significantly associated with MPP co-infection (p < 0.05). The prediction model demonstrated good discrimination, with an area under the curve (AUC) of 0.820 (95% CI: 0.760-0.879) for the ROC analysis. DCA confirmed the model's strong clinical utility. CONCLUSIONS: A prediction model based on influenza season, Fib level, fever duration, and CRP provide accurate identification of children at risk for MPP co-infected with influenza, demonstrating strong discrimination and clinical applicability. CLINICAL TRIAL: Not applicable.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。